颅内与椎管内脑膜瘤:土耳其单中心21年108例连续病例分析
该研究回顾性分析了土耳其一家三级中心2002至2023年间108例组织病理学确诊的颅内或椎管内脑膜瘤手术病例,描述临床、病理及手术特征,并按部位和切除程度探索复发。结果显示非颅底肿瘤全切除率较高而颅底较低,复发在颅底肿瘤中更常见,但事件数少且随访不完整。
要点
- 颅底肿瘤Simpson I级切除率仅13%,远低于非颅底肿瘤的83%。
- 颅底肿瘤复发率19%,非颅底4.2%,OR 5.3(95%CI 1.2-22.8;P=0.023)。
- 复发与切除程度无关(OR 2.9;95%CI 0.5-15.9;P=0.23)。
核心结论
- 本中心非颅底脑膜瘤多可完全切除,颅底则罕见,死亡仅见于术前有明显神经功能缺损者。
- 复发聚集于颅底肿瘤的发现基于9例事件和不完整随访,仅描述本中心经验,不能推广。
研究设计与样本
- 描述性总结临床、组织病理学(2021年WHO分类)和手术(Simpson分级)数据;采用Fisher精确检验按部位和切除程度探索复发。
主要发现
- 队列包括76例女性和32例男性,平均年龄59岁;86例(80%)为WHO 1级。
- 总体Simpson I级切除68例(63%),颅底肿瘤仅4/32(13%),非颅底肿瘤60/72(83%)。
- 术后病程良好86例(80%);并发症14例(13%);院内死亡2.8%(3/108),30天死亡0.9%(1/108)。
- 75例中位随访83个月,复发9例(8.3%),颅底19% vs 非颅底4.2%(OR 5.3;95%CI 1.2-22.8;P=0.023),切除程度间无差异(OR 2.9;95%CI 0.5-15.9;P=0.23)。
关键数值与推荐
- Simpson I级切除:总体63%(68/108),颅底13%(4/32),非颅底83%(60/72)。
- 复发:总体8.3%(9/108),颅底19% vs 非颅底4.2%,OR 5.3(95%CI 1.2-22.8;P=0.023)。
- 复发与切除程度:OR 2.9(95%CI 0.5-15.9;P=0.23)。
- 死亡率:院内2.8%(3/108),30天0.9%(1/108)。
临床怎么用
- 对于非颅底脑膜瘤,应争取Simpson I级切除以降低复发风险。
- 颅底脑膜瘤全切除困难,需权衡手术风险与残留复发风险,术后密切随访。
- 术前有明显神经功能缺损者死亡风险较高,围手术期管理需加强。
局限性
- 单中心回顾性设计,样本量有限(108例),结果外推需谨慎。
- 复发分析仅基于9例事件,且随访不完整(仅75例有随访数据),统计效能不足。
- 复发与切除程度的关系可能受混杂因素影响,未行多因素校正。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Single-center series remain useful for benchmarking local practice against the published literature. We report a 21-year experience with cranial and spinal meningiomas at one tertiary center in Türkiye. METHODS: We retrospectively reviewed 108 consecutive patients operated for histopathologically confirmed cranial or spinal meningioma at Zonguldak Bülent Ecevit University, Türkiye, from January 2002 to December 2023. Clinical, histopathological (2021 World Health Organization classification), and surgical (Simpson grade) data were summarized descriptively; recurrence was explored by location and extent of resection using Fisher's exact test. RESULTS: The cohort comprised 76 women and 32 men (mean age 59 years); 86 tumors (80%) were World Health Organization grade 1. Simpson grade I resection was achieved in 68 patients (63%) overall, but in only 4 of 32 skull-base tumors (13%) versus 60 of 72 nonskull-base tumors (83%). The postoperative course was favorable in 86 patients (80%); complications occurred in 14 (13%); in-hospital and 30-day mortality were 2.8% (3/108) and 0.9% (1/108), respectively. Over a median follow-up of 83 months in 75 patients, recurrence was documented in 9 (8.3%), more often in skull-base tumors (19% vs. 4.2%; odds ratio, 5.3; 95% confidence interval, 1.2-22.8; P = 0.023), but not by the extent of resection (odds ratio, 2.9; 95% confidence interval, 0.5-15.9; P = 0.23). CONCLUSIONS: In our hands, complete resection was achieved in most nonskull-base tumors but rarely at the skull base, and mortality was confined to patients presenting with a marked neurological deficit. The clustering of recurrence in skull-base tumors rests on 9 events and incomplete follow-up and describes our experience rather than a generalizable finding.
引用
- Aydın HA, Keskin E, Kalaycı M, et al. Cranial and Spinal Meningiomas: A 21-Year Single-Center Analysis of 108 Consecutive Patients in Türkiye. World Neurosurg. 2026. PMID: 42624361. doi:10.1016/j.wneu.2026.125265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。